SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934

DATE OF REPORT: OCTOBER 15, 2001

COLORADO MEDTECH, INC.
----------------------
(Exact name of registrant as specified in its charter)

<Table>

COLORADO 000-12471 84-0731006
---------------------------- ---------------- ------------------
(State or other jurisdiction (Commission File I.R.S. Employer
of incorporation) Number) Identification No.)
</Table>

6175 LONGBOW DRIVE
BOULDER, COLORADO 80301
-----------------------
(Address, including zip code, of principal executive offices)

(303) 530-2660
--------------
(Registrant's telephone number,
including area code)

ITEM 5. OTHER EVENTS.

Colorado MEDtech, Inc. issued a press release regarding resolution of
the issues identified in the Food and Drug Administration (FDA) warning letter
regarding the company's Longmont, Colorado medical device manufacturing
facility. The text of the press release is attached hereto as Exhibit 99.1.

ITEM 7. FINANCIAL STATEMENT AND EXHIBITS.

No. Description

99.1 Press release dated October 15, 2001

-2-

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

DATED, this 15th day of October, 2001.

COLORADO MEDTECH, INC.

By: /s/Stephen K. Onody
-----------------------------------
Stephen K. Onody
President and CEO

-3-

EXHIBIT INDEX

<Table>
<Caption>
EXHIBIT
NUMBER DESCRIPTION
------- -----------

99.1 Press release dated October 15, 2001
</Table>